Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
11/26/1996 | US5578442 Graft copolymers of polycationic species and water-soluble polymers, and use therefor |
11/26/1996 | US5578336 Candy centers and coatings |
11/26/1996 | US5578325 Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers |
11/26/1996 | US5578324 Peptide proteinaceous drug nasal powder composition |
11/26/1996 | US5578323 Proteinoid carriers and methods for preparation and use thereof |
11/26/1996 | US5578322 Mixture of hydrophobic substance and surfactant suppresses bad taste |
11/26/1996 | US5578321 Controlled release formulation of diltiazem hydrochloride |
11/26/1996 | US5578320 Method of dehydrating liposomes using protective sugars |
11/26/1996 | US5578319 Silicone pressure sensitive adhesive containing organic wax |
11/26/1996 | US5578316 Palatable pharmaceutical compositions |
11/26/1996 | US5578315 Fungicides, antiinflammatory agents, sustained release, treatment of oral diseases |
11/26/1996 | US5578314 Multiple layer alginate coatings of biological tissue for transplantation |
11/26/1996 | US5578310 Topical bioadhesive ointment compositions and their use in wound healing |
11/26/1996 | US5578309 For the treatment of candidiasis |
11/26/1996 | US5578307 Shaped articles containing plant extract(s), in particular pellets, and their pharmaceutical or cosmetic use |
11/26/1996 | US5578304 Compositions of digestive enzymes and salts of bile acids and process for preparation thereof |
11/26/1996 | US5578204 Apparatus for recovery and buffer exchange and/or concentration of dissolved macromolecules from a mixture of macromolecules |
11/26/1996 | US5577497 Dry powder inhaler |
11/26/1996 | CA2027592C Solid pharmaceutical preparations of active form of vitamin d_ of improved stability |
11/26/1996 | CA1338736C Microcrystals containing an active ingredient with affinity for phospholipids and at least one phospholipid; process for preparing the same |
11/21/1996 | WO1996036562A1 Bone substitution material and a method of its manufacture |
11/21/1996 | WO1996036433A1 Encapsulated product |
11/21/1996 | WO1996036370A1 Process for the depyrogenation of injectable pharmaceutical solutions |
11/21/1996 | WO1996036352A1 Liquid formulations for proteinic pharmaceuticals comprising at least 2 absorption enhancers |
11/21/1996 | WO1996036338A1 Bisacodyl dosage form for colonic delivery |
11/21/1996 | WO1996036329A1 Treatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acids |
11/21/1996 | WO1996036322A1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
11/21/1996 | WO1996036321A1 Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
11/21/1996 | WO1996036320A1 Fill compositions for soft elastic gel capsules |
11/21/1996 | WO1996036319A1 Pharmaceutical dosage form for colonic delivery |
11/21/1996 | WO1996036318A2 Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application |
11/21/1996 | WO1996036317A1 Production scale method of forming microparticles |
11/21/1996 | WO1996036316A1 Self-emulsifying formulations of lipophilic drugs |
11/21/1996 | WO1996036315A1 Sterilisable paste product for topical application |
11/21/1996 | WO1996036314A2 Method for drug delivery to the pulmonary system |
11/21/1996 | WO1996036296A1 Multiple layer, formed-in-place immunoisolation membrane structures for implantation of cells in host tissue |
11/21/1996 | WO1996036272A1 Controlled application of select ophthalmic agents and controlled disinfecting of multiple use articles |
11/21/1996 | WO1996036222A2 Improved method for controlling ectoparasites |
11/21/1996 | WO1996027375A3 Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
11/21/1996 | CA2221145A1 Self-emulsifying formulations of lipophilic drugs |
11/21/1996 | CA2220451A1 Methods and compositions for improving digestion and absorption in the small intestine |
11/21/1996 | CA2217852A1 Sterilisable paste product for topical application |
11/20/1996 | EP0743062A1 Effervescent preparation and production method thereof |
11/20/1996 | EP0743059A2 Process for applying antibacterial oral composition to dental implant areas |
11/20/1996 | EP0742818A1 Macroencapsulated secretory cells |
11/20/1996 | EP0742789A1 Pharmaceutically active compounds and liposomes, and methods of use therof |
11/20/1996 | EP0742716A1 Pharmaceutical composition for systemic transdermal administration containing the active agent morphine-6-glucuronide |
11/20/1996 | EP0742715A1 Oral liquid compositions containing paroxetine resinate |
11/20/1996 | EP0742714A1 Liquid pharmaceutical compositions comprising thyroid hormones |
11/20/1996 | EP0742713A1 Compositions and devices for controlled release of active ingredients |
11/20/1996 | EP0742712A1 Bilayered amoxycillin tablets |
11/20/1996 | EP0742711A1 Abuse resistant tablets |
11/20/1996 | EP0658103B1 Beads having a core coated with an antifungal and a polymer |
11/20/1996 | EP0648108B1 Prophylactic and therapeutical preparation against caries |
11/20/1996 | EP0641389A4 Reagent compositions for analytical testing. |
11/20/1996 | EP0575502B1 Polylactic acid-based implant susceptible of bioresorption containing an antibiotic |
11/20/1996 | EP0531529B1 Process for preparing aqueous suspension |
11/20/1996 | CN2240366Y Plaster with osmolarity controllable membrane |
11/20/1996 | CN1136281A Arteriosclerosis remedy |
11/20/1996 | CN1136274A Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
11/20/1996 | CN1136273A Liposomes with enhanced entrapment capacity, method and use |
11/20/1996 | CN1135915A Oral liquid for antibacteria, anti-inflammatory and strengthening body |
11/20/1996 | CN1135914A Oral liquid for health-care and skin protection |
11/20/1996 | CN1135911A Paste for common cold |
11/20/1996 | CN1135910A Capsule of Bidoukang |
11/20/1996 | CN1135909A Medicine for hyperosteogeny and wind-cold syndrome |
11/20/1996 | CN1135908A Medical food for curing acute and chronic pharyngitis |
11/20/1996 | CN1135907A Powder for regenerating tissue |
11/20/1996 | CN1135906A Medicine for ulcer of stomach and duodenum |
11/20/1996 | CN1135900A Ledebouriella polysaccharide and its preparation |
11/20/1996 | CN1135891A Application of RNA enzyme inhibition factor used as tumour inhibitor |
11/20/1996 | CN1135882A Brufen pellet |
11/19/1996 | US5576346 Administering a substituted chromone |
11/19/1996 | US5576345 Method and means for inhibiting posterior capsule opacification |
11/19/1996 | US5576344 Process for reducing the adverse taste and malodor associated with H2 -antagonists |
11/19/1996 | US5576311 Cyclodextrins as suspending agents for pharmaceutical suspensions |
11/19/1996 | US5576306 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
11/19/1996 | US5576305 Intercellular adhesion mediators |
11/19/1996 | US5576064 Liposoluble active ingredients; cosmetics |
11/19/1996 | US5576042 High intensity particulate polysaccharide based liquids |
11/19/1996 | US5576028 Method of preserving ophthalmic solutions and compositions therefor |
11/19/1996 | US5576025 Gastrointestinal mucosa-adherent matrixes, pharmaceutical preparations and a coating composition |
11/19/1996 | US5576024 Buffered matrix aspirin |
11/19/1996 | US5576022 Controlled release tacrine drug delivery systems and methods for preparing same |
11/19/1996 | US5576021 Hypotensive agents |
11/19/1996 | US5576020 Polyester coating material for use in large intestine-selective drug release pharmaceutical preparations |
11/19/1996 | US5576019 Forming tablets and capsules for drugs from cylinders and caps |
11/19/1996 | US5576018 Administering viricide to cerebrospinal fluid |
11/19/1996 | US5576017 Heterovesicular liposomes |
11/19/1996 | US5576016 Solid fat nanoemulsions as drug delivery vehicles |
11/19/1996 | US5576015 Substantially purified beta (1,3) finely ground yeast cell wall glucan composition with dermatological and nutritional uses |
11/19/1996 | US5576014 Intrabuccally dissolving compressed moldings and production process thereof |
11/19/1996 | US5576013 Treating vascular and neoplastic tissues |
11/19/1996 | US5576012 Pharmaceutical aqueous formulations containing a sparingly soluble pharmaceutical active compound with a solubilizing polymeric agent |
11/19/1996 | US5575994 Dermatological and cosmetic compositions |
11/19/1996 | US5575987 Method of producing sustained-release microcapsules |
11/19/1996 | US5575652 Process for applying antibacterial oral composition to dental implant areas |
11/14/1996 | WO1996035716A1 Fibroblast growth factor homologous factor-2 and methods of use |
11/14/1996 | WO1996035708A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
11/14/1996 | WO1996035566A1 Method and apparatus for forming compression dosage units within the product package |